"Don’t delay your care: you can schedule in-office appointments or video visits with NYU Langone doctors online. Every precaution is in place to ensure our facilities are safe so you can get the care you need. Visit our website for more details."

During the past decade, NYU Langone Transplant Institute conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "NYU Langone Transplant Institute" #1 collaborator was "Johns Hopkins University" with 1 trials as a collaborator and "PPD" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "NYU Langone Transplant Institute" are "Heart Failure" (1 trials), "Kidney Transplant Recipients" (1 trials) and "Liver Transplant Recipients" (1 trials). Many other conditions were trialed in "NYU Langone Transplant Institute" in a lesser frequency.

Most popular intervention types in "NYU Langone Transplant Institute" are "Biological" (1 trials), "Combination Product" (1 trials) and "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "Moderna Bivalent COVID-19 Vaccine" (1 trials), "Pfizer-BioNTech Bivalent COVID-19 Vaccine" (1 trials), "SOC IS Reduction" (1 trials), "SOC IS Regimen" (1 trials) and "Transplant with HCV positive donor, followed by surveillance and treatment of viremia" (1 trials). Other intervention names were less common.

The vast majority of trials in "NYU Langone Transplant Institute" are 2 trials for "All" genders.

Currently, there are NaN active trials in "NYU Langone Transplant Institute". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in NYU Langone Transplant Institute, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in NYU Langone Transplant Institute, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".